Variant · Snv
ANO5 NM_213599.3(ANO5):c.692G>T (p.Gly231Val)
CI-VAR-00005261Explore in graph →p.Gly231ValNM_213599.3:c.692G>TClinVar 2165 rs137854523
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 2165 | Likely pathogenic | reviewed by expert panel | 3 | Autosomal recessive limb-girdle muscular dystrophy type 2L; ANO5-related disorder; Gnathodiaphyseal dysplasia; Miyoshi muscular dystrophy 3; Hereditary fructosuria; Autosomal recessive limb-girdle muscular dystrophy; Acute rhabdomyolysis; Ovarian serous cystadenocarcinoma; Nonpapillary renal cell carcinoma | germline | 34 | Feb 24, 2026 | clinvar |